Early Endpoints of a Randomized Phase II Trial of Preoperative Chemotherapy with S-1/CDDP with or Without Trastuzumab Followed by Surgery for HER2-positive Resectable Gastric or Esophagogastric Junction Adenocarcinoma with Extensive Lymph Node Metastasis: Japan Clinical Oncology Group Study JCOG1301C (trigger Study).